Contracts & Grants

Information is courtesy of the Office of Sponsored Projects. Each listing includes the faculty member's name and school(s) appointments at The University of Texas Health Science Center at Houston, project title, contracting or granting agency, and funding amount.

New

H. Vernon Anderson, Medical School (MS), A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of Pexelizumab in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention, Duke University Medical Center, $28,298.

Roberto C. Arduino, MS, Baylor-UT Houston Center for AIDS Research, Baylor College of Medicine, $24,984.

Barbara K. Bailes, School of Nursing, New ANP and Diversity, Interdisciplinary, E-Health, HPDIP, University of Oklahoma, $35,354.

Ben J. Barnett, MS, An Open Label Trial of TMC125 in HIV-1 Infected Subjects Who Were Randomized to an Active Control Arm of Any Sponsor-Selected TMC125 Trial and Either Virologically Failed or Completed the Entire Treatment Period, Tibotec Pharmaceuticals, $15,347.

Ann L. Coker, School of Public Health (SPH), Understand Disparities in Cervical Cancer Survival, National Institutes of Health (NIH), National Cancer Institute, $351,472.

George Delclos, SPH, Occupational Asthmagens in Cleaners: A Focus Group Study, Texas Tech University, $22,340.

Michael J. Gambello, MS and Graduate School of Biomedical Sciences (GSBS), Genetic Characterization of Patients with Autism, NIH, National Institute of Child Health and Human Development, $148,604.

Richard M. Grimes, SPH, Baylor-UT Houston Center for AIDS Research, Baylor College of Medicine, $15,138.

John R. Herbold, SPH, The Regional Training Medical Consultation Center (RTMCC), The University of Texas at Tyler, $120,996.

Roger Janz, MS and GSBS, Role of SV2B in Ribbon Synapses of the Retina, NIH, National Eye Institute, $1,460,669.

Kristy M. Lillibridge, SPH, Epidemiology of Arboviral Encephalomyelitis in Houston, NIH, National Institute of Allergy and Infectious Diseases, $363,410.

Scott R. Lillibridge, SPH, Border Health Training Initiative, Texas Department of State Health Services, $999,537.

Michael Mauk, MS and GSBS, Forebrain-Cerebellum Interactions in Trace Conditioning, NIH, National Institute of Mental Health, $1,476,153.

Hadar J. Merhav, MS, Anti-Viral Pre-Emptive Treatment for the Treatment of HCV Following Orthotopic Liver Transplant, Astellas Pharma US Inc., $240,000; and Blood, Bile and Tissue Pharmacokinetics of Single Dose Liposomal Amphotericin B (Ambisome) in Liver Transplant Patients, Astellas Pharma US Inc., $10,000.

John Mohr, MS, Pharmacokinetic and Pharmacodynamic Evaluation of Single Dose Intravenous Daptomycin in Patients with Thermal Burn Injury, Cubist Pharmaceuticals Inc., $72,649.

John D. Reveille, MS and GSBS, Polymorphic Human Leukocyte Antigen, UT M. D. Anderson Cancer Center, $12,603.

Kevin D. Ridge, MS, Isotope-Labeling of G-Protein Coupled Receptors for Structural Analysis by NMR, Robert A.Welch Foundation, $150,000.

Richard W. Smalling, MS, High-Frequency IVUS Viscoelasticity Imaging to Detect and Differentiate Vulnerable Atheorsclerotic Plaques, UT Austin, $8,090.

Eric Thomas, MS, Assessing Climate Across Ascension System, Johns Hopkins University, $32,120.

Charles T. Van Buren, MS, A Randomized, Open-Label, Comparative Evaluation of the Safety and Efficacy of Sirolimus Versus Cyclosporine when Combined in a Regimen Containing Basiliximab, Mycophenolate Mofetil, and Corticosteroids in Primary De Novo Renal Allograft Recipients, Wyeth Pharmaceuticals, $251,953.

Kirk L. Von Sternberg, MS, Analysis of Project Choices Efficacy Study, Batelle Memorial Institute, $34,379.

Renewal

Ferid Murad, MS, GSBS and Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, Nitrotyrosine Formation and Function, Robert A.Welch Foundation, $240,000.

C. S. Raman, MS and GSBS, Structural Chemistry of Heme-Dependent Catalysis and Sensing, Robert A.Welch Foundation, $150,000.